DNA Nanosponge for Adsorption and Clearance of Intracellular miR-21 and Enhanced Antitumor Chemotherapy

ACS Appl Mater Interfaces. 2019 Dec 18;11(50):46604-46613. doi: 10.1021/acsami.9b18282. Epub 2019 Dec 6.

Abstract

Antisense oligonucleotide (ASO)-induced cellular signaling pathway alteration is evolving as a promising therapeutic strategy for improving antitumor chemotherapy. However, the inherent instability and inefficiency of ASO delivery remain major hurdles for its application. Herein, we developed a self-assembled DNA nanosponge (DNS) for adsorption and clearance of intracellular miR-21. The densely packed DNA nanostructure is able to provide large amounts of repeated ASO copies for efficient capturing of miR-21 and inhibiting the miRNAs function in mammalian cells. The cell apoptosis-related protein expression (Bcl-2, Bax, and cleaved caspase-3/9) can be obviously interrupted with the delivery of DNS. Besides, we have shown that the DNS can efficiently carry Dox for chemotherapy and inducing tumor cell (MCF-7) apoptosis meanwhile has little affect to normal cells (Hs578 Bst). These polymeric DNS systems mimic the natural RNA circle-based miRNA sponges and have potential to be applied for specific and efficient regulation of gene expression in tumor cells for synergistic antitumor chemotherapy.

Keywords: DNA nanosponge; antisense oligonucleotide; cell apoptosis; enhanced chemotherapy; miRNA-21.

MeSH terms

  • Adsorption / drug effects
  • Animals
  • Apoptosis / drug effects
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics
  • Breast Neoplasms / pathology
  • Caspase 3 / genetics
  • Cytoplasm / genetics
  • DNA / antagonists & inhibitors
  • DNA / genetics*
  • Doxorubicin / chemistry
  • Doxorubicin / pharmacology
  • Female
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • MCF-7 Cells
  • Mice
  • MicroRNAs / antagonists & inhibitors
  • MicroRNAs / genetics*
  • Nanoparticles / chemistry
  • Oligonucleotides, Antisense / genetics
  • Oligonucleotides, Antisense / pharmacology*
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • RNA, Circular / genetics
  • Xenograft Model Antitumor Assays

Substances

  • BCL2 protein, human
  • MIRN21 microRNA, human
  • MicroRNAs
  • Oligonucleotides, Antisense
  • Proto-Oncogene Proteins c-bcl-2
  • RNA, Circular
  • Doxorubicin
  • DNA
  • CASP3 protein, human
  • Caspase 3